Figure 1. Flowchart for suggested eligibility criteria for anti-amyloid therapy.

Abbreviations: MCI, mild cognitive impairment; CDR, Clinical Dementia Rating; MMSE, Mini-Mental State Examination; FAST, Functional Assessment Staging Tool; MRI, magnetic resonance imaging; PET, positron emission tomography; Aβ, amyloid beta; CSF, cerebrospinal fluid; ApoE, apolipoprotein E gene.